Copyright
©The Author(s) 2022.
World J Clin Cases. Oct 6, 2022; 10(28): 10077-10084
Published online Oct 6, 2022. doi: 10.12998/wjcc.v10.i28.10077
Published online Oct 6, 2022. doi: 10.12998/wjcc.v10.i28.10077
Table 1 National Institutes of Health Stroke Scale score compared between the two at different time points (mean ± SD)
Groups | n | Before the operation | 24 h after the operation | 7 d after the operation | Before discharge |
Endovascular treatment group | 50 | 16.43 ± 6.34 | 12.23 ± 5.63 | 10.35 ± 4.01 | 6.83 ± 1.23 |
Medical treatment group | 50 | 17.09 ± 5.98 | 14.11 ± 6.03 | 12.38 ± 5.22 | 8.23 ± 2.09 |
t value | 1.023 | 4.522 | 7.093 | 13.12 | |
P value | 0.276 | 0.042 | 0.024 | 0.001 |
Table 2 Incidence of early deterioration of neurological function, n (%)
Groups | n | Repeated vascular occlusion | Tissue edema | Cerebral hemorrhage | Overall incidence |
Endovascular treatment | 50 | 3 (6.0) | 1 (2.0) | 0 (0.0) | 4 (8.0) |
Medical treatment group | 50 | 5 (10.0) | 3 (6.0) | 1 (2.0) | 9 (18.0) |
χ2 value | 9.234 | ||||
P value | 0.001 |
Table 3 Comparison of the modified Rankin scale and activity of daily living scores between the two groups (mean ± SD)
Groups | n | mRS score | ADL score |
Endovascular treatment | 50 | 4.11 ± 0.24 | 59.93 ± 15.73 |
Medical treatment group | 50 | 5.09 ± 0.83 | 46.71 ± 16.22 |
t value | 6.172 | 5.522 | |
P value | 0.031 | 0.035 |
- Citation: Kou WH, Wang XQ, Yang JS, Qiao N, Nie XH, Yu AM, Song AX, Xue Q. Endovascular treatment vs drug therapy alone in patients with mild ischemic stroke and large infarct cores. World J Clin Cases 2022; 10(28): 10077-10084
- URL: https://www.wjgnet.com/2307-8960/full/v10/i28/10077.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i28.10077